iCamuno starts with induced pluripotent stem cells (iPSCs) and uses cutting-edge technologies such as gene editing, and algorithm-driven cellular differentiation to empower cells. Guided by the philosophy of “demand-oriented, patient-centered”, we are changing the face of tumor immunotherapy and regenerative medicine, providing patients with universal, effective, and affordable cell therapies.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 苏州, Cn
- Industry
- Biotechnology
- Website
- https://icamunobio.com/
- HQ
- 苏州
Icamuno Biotherapeutics Pty Ltd Questions
Icamuno Biotherapeutics Pty Ltd's website is https://icamunobio.com/
Icamuno Biotherapeutics Pty Ltd's LinkedIn profile is https://cn.linkedin.com/company/icamuno-biotherapeutics-pty-ltd
Icamuno Biotherapeutics Pty Ltd has
9 employees.
View email and phone details for 9
employees at Icamuno Biotherapeutics Pty Ltd.
Icamuno Biotherapeutics Pty Ltd's industry is
Biotechnology
Icamuno Biotherapeutics Pty Ltd's top competitors are
Sienna Cancer Diagnostics - A Bard1 Life Sciences Company,
Rhythm Biosciences Limited,
Cartherics Pty Ltd,
I Peace, Inc.| Cell And Gene Therapy Manufacturing, Cgmp Ipscs | Cdmo,
Inoviq Ltd (Asx:iiq),
Invion Limited,
Genetype,
Anteotech Ltd,
Vivazome Therapeutics,
Culturon®.
Icamuno Biotherapeutics Pty Ltd's categories are Biotechnology
Icamuno Biotherapeutics Pty Ltd's founding year is 2021
